Cart (0 Items)
Your cart is currently empty.
View ProductsRomilkimab Biosimilar – Anti-IL13, IL4 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | [VH-VH' Gamma1 + VL-VL' kappa (bispecific) |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Romilkimab Biosimilar - Anti-IL13, IL4 mAb - Research Grade |
|---|---|
| Source | IMGT/mAb-DB 794 |
| Species | Human |
| Expression system | Mammalian cells |
| Molecular weight | LC: 36kDa HC: 63kDa |
| Purity | >85% |
| Buffer | PBS pH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | 4°C for short term; -20°C for long term |
| Brand | ProteoGenix |
| Aliases /Synonyms | Romilkimab,Romilkimab,IL13, IL4,anti-IL13, IL4 |
| Reference | PX-TA1027 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | [VH-VH' Gamma1 + VL-VL' kappa (bispecific) |
| Clonality | Monoclonal Antibody |
Description of Romilkimab Biosimilar - Anti-IL13, IL4 mAb - Research Grade
General information about Romilkimab
Romilkimab is an engineered, humanised, bispecific immunoglobulin-G4 antibody that binds and neutralizes IL-4/IL-13 making it ideal for exploration in fibrosis, This product is for research use only.
SDS-PAGE for Romilkimab Biosimilar - Anti-IL13, IL4 mAb
Romilkimab Biosimilar - Anti-IL13, IL4 mAb, on SDS-PAGE under non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Antigen
IL13 recombinant protein
PX-P5175 385€
Antigen
IL13, N-His, recombinant protein
PX-P5778 385€
Antigen
Human CD213a2 / IL13RA2 recombinant protein
PX-P6041 385€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.